108th CONGRESS
1st Session
S. 1740
To amend the September 11th Victim Compensation Fund of 2001 (Public
Law 107-42; 49 U.S.C. 40101 note) to provide compensation for the United States
Citizens who were victims of a terrorist-related laboratory-confirmed anthrax
infection in the United States during the period beginning on September 13,
2001, through November 30, 2001, on the same basis as compensation is provided
to victims of the terrorist-related aircraft crashes on September 11, 2001.
IN THE SENATE OF THE UNITED STATES
October 16, 2003
Mr. LEAHY (for himself, Mr. DASCHLE, Mr. LAUTENBERG, Mr. NELSON of Florida,
Mr. FEINGOLD, Mr. CORZINE, Ms. MIKULSKI, Mr. SARBANES, Mrs. CLINTON, Mr. LIEBERMAN,
and Mr. DODD) introduced the following bill; which was read twice and referred
to the Committee on the Judiciary
A BILL
To amend the September 11th Victim Compensation Fund of 2001 (Public
Law 107-42; 49 U.S.C. 40101 note) to provide compensation for the United States
Citizens who were victims of a terrorist-related laboratory-confirmed anthrax
infection in the United States during the period beginning on September 13,
2001, through November 30, 2001, on the same basis as compensation is provided
to victims of the terrorist-related aircraft crashes on September 11, 2001.
Be it enacted by the Senate and House of Representatives of the United
States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the `Anthrax Victims Fund Fairness Act of 2003'.
SEC. 2. REFERENCES.
Except as otherwise expressly provided, wherever in this Act an amendment
or repeal is expressed in terms of an amendment to, or repeal of, a section
or other provision, the reference shall be considered a reference to the September
11th Victim Compensation Fund of 2001 (Public Law 107-42; 49 U.S.C. 40101
note).
SEC. 3. COMPENSATION FOR VICTIMS OF TERRORIST ACTS.
(a) DEFINITIONS- Section 402(6) is amended by inserting `or related to a terrorist-related
laboratory-confirmed anthrax infection in the United States during the period
beginning on September 13, 2001, through November 30, 2001' before the period.
(b) PURPOSE- Section 403 is amended by inserting `or as a result of a terrorist-related
laboratory-confirmed anthrax infection in the United States during the period
beginning on September 13, 2001, through November 30, 2001' before the period.
(c) DETERMINATION OF ELIGIBILITY FOR COMPENSATION-
(1) CLAIM FORM CONTENTS- Section 405(a)(2)(B) is amended--
(A) in clause (i), by inserting `or as a result of a terrorist-related
laboratory-confirmed anthrax infection in the United States during the
period beginning on September 13, 2001, through November 30, 2001' before
the semicolon;
(B) in clause (ii), by inserting `or terrorist-related laboratory-confirmed
anthrax infection' before the semicolon; and
(C) in clause (iii), by inserting `or terrorist-related laboratory-confirmed
anthrax infection' before the period.
(2) LIMITATION- Section 405(a)(3) is amended by striking `2 years' and inserting
`3 years'.
(3) COLLATERAL COMPENSATION- Section 405(b)(6) is amended by inserting `or
as a result of a terrorist-related laboratory-confirmed anthrax infection
in the United States during the period beginning on September 13, 2001,
through November 30, 2001' before the period.
(A) INDIVIDUALS- Section 405(c)(2) is amended--
(i) in subparagraph (B), by striking `or' after the semicolon;
(ii) in subparagraph (C)--
(I) by striking `or (B)' and inserting `, (B), or (C)'; and
(II) striking `(C)' and inserting `(D)'; and
(iii) by inserting after subparagraph (B) the following:
`(C) an individual who suffered physical harm or death as a result of
a terrorist-related laboratory-confirmed anthrax infection in the United
States during the period beginning on September 13, 2001, through November
30, 2001; or '.
(B) REQUIREMENTS- Section 405(c)(3) is amended--
(i) in the heading for subparagraph (B) by inserting `RELATING TO SEPTEMBER
11TH TERRORIST ACTS' before the period; and
(ii) by adding at the end the following:
`(C) LIMITATION ON CIVIL ACTION RELATING TO OTHER TERRORIST ACTS-
`(i) IN GENERAL- Upon the submission of a claim under this title, the
claimant waives the right to file a civil action (or to be a party to
an action) in any Federal or State court for damages sustained as a
result of a terrorist-related laboratory-confirmed anthrax infection
in the United States during the period beginning on September 13, 2001,
through November 30, 2001. The preceding sentence does not apply to
a civil action to recover any collateral source obligation based on
contract, or to a civil action against any person who is a knowing participant
in any conspiracy to commit any terrorist act.
`(ii) PENDING ACTIONS- In the case of an individual who is a party to
a civil action described in clause (i), such individual may not submit
a claim under this title unless such individual withdraws from such
action by the date that is 90 days after the date on which regulations
are promulgated under section 4 of the Anthrax Victims Fund Fairness
Act of 2003.
`(D) INDIVIDUALS WITH PRIOR COMPENSATION-
`(i) IN GENERAL- Subject to clause (ii), an individual is not an eligible
individual for purposes of this subsection if that individual, or the
estate of that individual, has received any compensation from a civil
action or settlement based on tort related to a terrorist-related laboratory-confirmed
anthrax infection in the United States during the period beginning on
September 13, 2001, through November 30, 2001.
`(ii) EXCEPTION- Clause (i) shall not apply to compensation received
from a civil action against any person who is a knowing participant
in any conspiracy to commit any terrorist act.'.
(C) INELIGIBILITY OF PARTICIPANTS AND CONSPIRATORS- Section 405(c) is
amended by adding at the end the following:
`(4) INELIGIBILITY OF PARTICIPANTS AND CONSPIRATORS- An individual, or a
representative of that individual, shall not be eligible to receive compensation
under this title if that individual is identified by the Attorney General
to have been a participant or conspirator in a terrorist-related laboratory-confirmed
anthrax infection in the United States during the period beginning on September
13, 2001, through November 30, 2001.'.
SEC. 4. REGULATIONS.
Not later than 90 days after the date of enactment of this Act, the Attorney
General, in consultation with the Special Master, shall promulgate regulations
to carry out the amendments made by this Act, including regulations with respect
to--
(1) forms to be used in submitting claims under this Act;
(2) the information to be included in such forms;
(3) procedures for hearing and the presentation of evidence;
(4) procedures to assist an individual in filing and pursuing claims under
this Act; and
(5) other matters determined appropriate by the Attorney General.
END